-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Leaders from the Science and Technology Department of the Ministry of Industry and Information Technology of the People’s Republic of China Conduct a Research Visit to Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisiyao Group
Category:
TIME：2020-03-12
【SUMMARY】
On March 10, Bi Kaichun, First-Level Inspector of the Science and Technology Department of the Ministry of Industry and Information Technology of the State Council and Head of the Tenth Special Task Force of the Medical Supplies Guarantee Group under the Joint Prevention and Control Mechanism of the State Council for the Novel Coronavirus Pneumonia Epidemic, who also serves as a member of the Standing Committee of the CPC Cangzhou Municipal Committee and Secretary of the Party Working Committee of the Bohai New Area,
On March 10, Bi Kaichun, First-Level Inspector of the Science and Technology Department of the Ministry of Industry and Information Technology of the People’s Republic of China and Head of the Tenth Special Task Force under the Medical Supplies Guarantee Group of the State Council Joint Prevention and Control Mechanism for the Novel Coronavirus Pneumonia Epidemic, conducted a research visit to Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisiyao Group, accompanied by Zhang Guodong, a member of the Standing Committee of the CPC Cangzhou Municipal Committee, Secretary of the Party Working Committee and Director of the Management Committee of the Bohai New Area, and Head of the Leading Group for COVID-19 Prevention and Control in the Bohai New Area.
▲ Bi Kaichun, First-Level Inspector of the Science and Technology Department of the Ministry of Industry and Information Technology of the People’s Republic of China and Head of the Tenth Special Task Force of the Medical Supplies Guarantee Group under the Joint Prevention and Control Mechanism of the State Council for Responding to the Novel Coronavirus Pneumonia Epidemic, conducted a field inspection at Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group. (Third from the left in the front row.)
Bi Kaichun held a detailed discussion with Gao Shuping, Chairperson of Hebei Guangxiang Pharmaceutical, on the implementation of the company’s epidemic prevention and control measures and the resumption of work and production. Bi Kaichun commended the company for the significant achievements it has made in epidemic prevention and control as well as in economic and social development. He encouraged the company to steadfastly regard innovation as the primary driving force behind its development, continuously enhance quality and efficiency, prioritize scientific and technological research and development and the commercialization of scientific and technological achievements, actively explore the construction of industrial internet platforms, and constantly strengthen its innovative capacity and competitiveness.
Gao Shuping stated that they will continue to rigorously implement all prevention and control measures and comprehensively advance the resumption of production and attainment of full operational efficiency. At the same time, they will intensify efforts in scientific and technological innovation, strengthen and expand the enterprise, and make greater contributions to advancing the development of the coastal economic belt.
Relevant officials from the Cangzhou Bohai New Area accompanied the inspection.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
Business License
